Nouzhan Sehati, MD
Neurological Surgery · Burbank, CANPI 1245396803
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Globus Medical accounts for 68.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $180 and has fallen 86.6% since, to $24 in 2024. That places this record below the midpoint for neurological surgery clinicians in CA, where the typical reported total is $3,356.
Across 8 payments — averaging $30.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$166
- Boston Scientific$24
- Providence Medical Technology, Inc.$24
- Medtronic$15
- GE HealthCare$15
What the payments were for
- Food & beverage$243100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 3 | $166 |
| Boston Scientific | 1 | $24 |
| Providence Medical Technology, Inc. | 2 | $24 |
| Medtronic | 1 | $15 |
| GE HealthCare | 1 | $15 |
How this compares
$243 in reported general payments places this provider in the 15th percentile of 773 neurological surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $308 |
| Gabapentin | 29 | $269 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $217 |
| Pregabalin | 27 | $168 |
| Cephalexin | 19 | $58 |
| Trazodone Hcl | 11 | $41 |
| Tramadol Hcl | 14 | $30 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Burbank
- Christopher AmesSan Francisco$7.1M
- Larry KhooLos Angeles$2.8M
- Samy AbdouSan Diego$2.4M
- Bret AbshireMurrieta$2.3M
- William TaylorSan Diego$2.1M
- Tooraj GravoriEncino$2M
- Ali MesiwalaRancho Cucamonga$1.5M
- Joseph OsorioSan Diego$1.3M
- Ian JohnsonFresno$1.3M
- Aaron Cohen-GadolLos Angeles$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.